nitrofen has been researched along with Pulmonary Arterial Remodeling in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hirako-Takamura, S; Iitani, Y; Imai, K; Ito, Y; Kajiyama, H; Kotani, T; Miki, R; Miura, M; Moriyama, Y; Nakano-Kobayashi, T; Tano, S; Toyokuni, S; Tsuda, H; Ushida, T | 1 |
| Bair, H; Harting, MT; Jin, D; Lu, J; Olson, SD; Zhaorigetu, S | 1 |
| Alvarez, L; Corcionivoschi, N; Friedmacher, F; Gosemann, JH; Hofmann, A; Kuebler, JF; Lacher, M; Puri, P; Rittinghausen, S; Suttkus, A; Zimmer, J | 1 |
| Ahmed, M; Alabed, Y; Ayasolla, K; Benveniste, H; Miller, EJ; Nasim, M; Ochani, K; Orner, D; Patel, H; Perveen, S; Salerno, M; Vaska, P; Zagloul, N; Zuo, Z | 1 |
| Antounians, L; Montalva, L; Zani, A | 1 |
| Gómez-Meda, BC; Lemus-Varela, Mde L; Melnikov, V; Ornelas-Aguirre, JM; Soliz, A; Torres-Mendoza, BM; Zamora-Perez, AL; Zúñiga-González, GM | 1 |
| Da Costa, AM; de Medina, G; Dewachter, C; Dewachter, L; Hupkens, E; Makanga, M; Maruyama, H; Naeije, R | 1 |
| Hirako, S; Imai, K; Kikkawa, F; Kotani, T; Li, H; Mano, Y; Nakano, T; Sumigama, S; Toyokuni, S; Tsuda, H | 1 |
| Buscop-van Kempen, MJ; Dzyubachyk, O; Koning, AH; Kool, HM; Mous, DS; Rottier, RJ; Tibboel, D; Wijnen, RM | 1 |
1 review(s) available for nitrofen and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Endothelial Cells; Female; Hernias, Diaphragmatic, Congenital; Humans; Hypertension, Pulmonary; Infant, Newborn; Myocytes, Smooth Muscle; Phenyl Ethers; Pregnancy; Pulmonary Artery; Rats; Risk Factors; Vascular Remodeling | 2019 |
8 other study(ies) available for nitrofen and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Prenatal Molecular Hydrogen Administration Ameliorates Several Findings in Nitrofen-Induced Congenital Diaphragmatic Hernia.
Topics: Animals; Animals, Newborn; Antioxidants; Deuterium Oxide; Disease Models, Animal; Female; Hernias, Diaphragmatic, Congenital; Hydrogen; Hypertension, Pulmonary; Lung; Male; Organogenesis; Phenyl Ethers; Pregnancy; Pulmonary Artery; Pulmonary Surfactants; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2021 |
Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model.
Topics: Animals; Animals, Newborn; Carrier Proteins; Caveolin 1; Disease Models, Animal; Endothelium, Vascular; Female; Gestational Age; Hernias, Diaphragmatic, Congenital; Maternal Exposure; Myosin Light Chains; Nitric Oxide Synthase Type III; Phenyl Ethers; Phosphorylation; Pregnancy; Prenatal Exposure Delayed Effects; Pulmonary Artery; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Remodeling | 2018 |
Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; Female; Gene Expression; Hernias, Diaphragmatic, Congenital; Immunohistochemistry; Lung; Macrophages; Monocytes; Phenyl Ethers; Pregnancy; Prenatal Care; Rats; RNA, Messenger; Rosiglitazone; Vascular Remodeling | 2018 |
MIF inhibition enhances pulmonary angiogenesis and lung development in congenital diaphragmatic hernia.
Topics: Animals; Animals, Newborn; Body Weight; Disease Models, Animal; Female; Hemodynamics; Hernias, Diaphragmatic, Congenital; Hypertension, Pulmonary; Immunity, Innate; Inflammation; Intramolecular Oxidoreductases; Lung; Macrophage Migration-Inhibitory Factors; Maternal Exposure; Neovascularization, Physiologic; Phenyl Ethers; Pregnancy; Pregnancy, Animal; Rats; Systole; Tomography, X-Ray Computed; Vascular Remodeling; Ventricular Function, Right | 2019 |
Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia.
Topics: Animals; Bosentan; Disease Models, Animal; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Piperazines; Pregnancy; Purines; Random Allocation; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Vascular Remodeling | 2014 |
Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia.
Topics: Animals; Apoptosis; Bone Morphogenetic Protein Receptors, Type II; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Pregnancy; Rats, Sprague-Dawley; Simvastatin; Vascular Remodeling | 2015 |
Antenatal Saireito (TJ-114) Can Improve Pulmonary Hypoplasia and Pulmonary Vascular Remodeling in Nitrofen-Induced Congenital Diaphragmatic Hernia.
Topics: Abnormalities, Multiple; Animals; Disease Models, Animal; Dogs; Drugs, Chinese Herbal; Female; Hernias, Diaphragmatic, Congenital; Lung; Lung Diseases; Phenyl Ethers; Rats; Rats, Sprague-Dawley; Vascular Remodeling | 2016 |
Clinically relevant timing of antenatal sildenafil treatment reduces pulmonary vascular remodeling in congenital diaphragmatic hernia.
Topics: Animals; Drug Evaluation, Preclinical; Female; Hernias, Diaphragmatic, Congenital; Lung; Maternal Exposure; Maternal-Fetal Exchange; Phenyl Ethers; Phosphodiesterase 5 Inhibitors; Pregnancy; Rats, Sprague-Dawley; Sildenafil Citrate; Vascular Remodeling | 2016 |